Related Experiment Video

Updated: Jun 12, 2026

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression

Sean L Petersen1, Michael Peyton, John D Minna

  • 1Howard Hughes Medical Institute and Department of Biochemistry and Hamon Center for Therapeutic Oncology Research and Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Proceedings of the National Academy of Sciences of the United States of America
|June 16, 2010
PubMed

Insights

Cancer cells resist Smac mimetic-induced apoptosis by upregulating cIAP2. Modulating NF-kappaB or using PI3K inhibitors overcomes this resistance, restoring sensitivity to cancer cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Smac mimetics induce cancer cell death by targeting TNFalpha-dependent pathways.
  • Proteasome degradation of cellular inhibitor of apoptosis 1 (cIAP1) and cIAP2 is crucial for this process.
  • Degradation of cIAPs releases RIPK1, facilitating caspase-8 activation and apoptosis.

Purpose of the Study:

  • To investigate mechanisms of cancer cell resistance to Smac mimetic/TNFalpha-induced apoptosis.
  • To identify strategies for overcoming such resistance.

Main Methods:

  • Analysis of human cancer cell lines resistant to Smac mimetics.
  • Investigating the role of cIAP2 upregulation and its regulation by TNFalpha/NF-kappaB signaling.
  • Evaluating the impact of NF-kappaB modulation and PI3K inhibition (LY294002) on cell sensitivity.

Main Results:

  • Cancer cells evade apoptosis by upregulating cIAP2, which becomes refractory to degradation.
  • TNFalpha induces cIAP2 via NF-kappaB signaling.
  • Modulating NF-kappaB signaling sensitized resistant cells to Smac mimetics.
  • PI3K signaling also regulates cIAP2; LY294002 suppressed cIAP2 upregulation and restored sensitivity.

Conclusions:

  • cIAP2 upregulation is a key resistance mechanism to Smac mimetics in cancer.
  • Targeting NF-kappaB or PI3K pathways can overcome Smac mimetic resistance.
  • Combined therapeutic strategies hold promise for enhancing cancer treatment efficacy.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...